sales@fusionmarketresearch.com + (210) 775-2636 (USA)

Healthcare and Pharmaceuticals


Research Reports

United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By Pregnancy Risk Level (High & Average Risk), Major Deals, Reimbursement, Key Company Profiles & Demand Forecasts to 2018 - 2023

March 2020

The report titled “United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By Pregnancy Risk Level (High & Average Risk), Major Deals, Reimbursement, Key Company Profiles & Demand Forecasts to 2018 - 2023” examines the market dynamics, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for NIPT test in United States. The research includes historic data from 2015 to 2017 and forecasts until 2023. Long–term Growth Projection: • United States is anticipated to be the most attractive market in the Non-Invasive Prenatal Testing(NIPT) industry • United States Non-Invasive Prenatal Testing(NIPT) is expected to register a faster value growth during 2018 - 2023 • The Potential United States Non-Invasive Prenatal Testing(NIPT) Market is set to cross USD 2.5 Billion by 2023 • MaterniT21 PLUS, Harmony, Verifi, Panorama are the popular test in the United States Non-Invasive Prenatal Testing(NIPT) Market The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2023. The report also includes assessment of comparative test analysis by companies.It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT test market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market. The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market. The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are: Illumina, Natera, Quest Diagnostics, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche) Major and Promising NIPT test covered in the report are as follows: MaterniT21 PLUS, VisibiliT, MaterniT21 GENOME,Harmony, Verifi, Panorama,Vistara andQNatal Advanced The Latest Industry Data Included in this Report: • Actual NIPT Test Volume& Market Revenue (2015 - 2023) • Average Risk Actual NIPT Test Volume & Market Revenue (2015 - 2023) • High Risk Actual NIPT Test Volume & Market Revenue (2015 - 2023) • Potential NIPT Test Volume& Market Revenue (2015 - 2023) • Average Risk Potential NIPT Test Volume & Market Revenue (2015 - 2023) • High Risk Potential NIPT Test Volume & Market Revenue (2015 - 2023) • NIPT Test Market - Reimbursement & Regulation System • NIPT Test Implementation in High–Income Countries • Comparative Test Analysis – By Companies • Major Deals in Non–Invasive Prenatal Testing Market • Key Companies Analysis • Key Market Drivers and Inhibitors of the United States NIPT Test Market


China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 - 2025: Clinical Chemistry,Immunoassay,Molecular Testing,SMBG,Point of Care Testing (POCT), Hematology,Coagulation,Microbiology,Genetic Testing,Infectious Diagnostics,Histology and Cytology

March 2020

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 - 2025. The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories. “China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 - 2025: Clinical Chemistry,Immunoassay,Molecular Testing,SMBG,Point of Care Testing (POCT), Hematology,Coagulation,Microbiology,Genetic Testing,Infectious Diagnostics,Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025. The report contains a granular analysis of the China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025.A comprehensive analysis has been done on market share of China in vitro diagnostics by application, end-user and company share by revenue. The report also includes assessment of in vitro diagnostics regulation in China.Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers,restraints, trends and opportunities of the China in vitro diagnostics market. Market Segmentation by Application and Analysis (2012 - 2025) • Clinical Chemistry • Immunoassay • Molecular Testing • Self–Monitoring of Blood Glucose (SMBG) • Point of Care Testing (POCT) • Hematology • Coagulation • Microbiology • Genetic Testing • Infectious Diagnostics • Histology and Cytology The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are: • Roche Diagnostics • Abbott Laboratories • Siemens Healthineers • Sysmex Corporation • Mindray Medical International Limited • Beckman Coulter Inc • Shanghai Fosun Pharmaceutical Group • Thermo Fisher Scientific Inc • Hologic Inc • Qiagen • Cepheid • Bio-Rad Laboratories Inc • Da An Gene Co. Ltd • Shanghai Kehua Bio–Engineering Co. Ltd. The Latest Industry Data Included in this Report: • China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025) • China In Vitro Diagnostics Market Dynamics • China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025) • China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025) • China In Vitro Diagnostics Market, Company Share by Revenue, 2017 • China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017 • Assessmentof In Vitro Diagnostics Regulation in China • Major Partnership Deals in China In Vitro Diagnostics Market • Recent Developments in China In Vitro Diagnostics Market • Overview of Key Companies in China In Vitro Diagnostics Market


Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 - 2025

March 2020

United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccines development. “Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 - 2025”provides a unique tool for evaluating the market, highlighting opportunities, supporting strategic and tactical decision–making. This report recognizes that in this rapidly–evolving and competitive environment, up–to–date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments and focuses on United States pediatric vaccines market. The report also provides clear insight into current and future developments of the United States pediatric vaccines market. Further more, this report provides a deep and thorough evaluation of the top 10 pediatric Vaccines by disease indication. On the basis of disease indication, the top 10 pediatric Vaccines provide an in-depth analysis of doses administered number of children being vaccinated and market size. The research includes historic data from 2010 to 2017 and forecasts until 2025. The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccines market. The report concludes with the profiles of major players in the United States pediatric vaccines market. The key market players are evaluated on various parameters such as company overview, pediatric vaccines portfolios and latest development & trends of the pediatric vaccines market. The Major Companies dominating this Market for its Products, Services and Continuous Product Developments are: • Sanofi Pasteur • GlaxoSmithKline(GSK) • Merck & Co. • Pfizer Inc • Grifols Major Pediatric Vaccines (Disease Indication) Covered Under This Report are: • Diphtheria, Tetanus & Pertussis (DTap) • Hepatitis A • Varicella/Chicken Pox • Pneumococcal • Haemophilus Influenzae Type B (HIB) • Polio • Rotavirus • Hepatitis B • Influenza Pediatric • Measles, Mumps & Rubella (MMR) The Latest Industry Data Included in this Report: • United States Pediatric Vaccines Market Size & Analysis ,2010 – 2025 • United States Pediatric Vaccines Market Share and Y–o–Y Growth (%),2010 - 2025 • United States Pediatric Vaccines Market by Disease Indication ,2010 – 2025 • 10 Pediatric Vaccines Doses Administered (Volume),2010 - 2025 • Number of Children Being Vaccinated (Volume)2010 - 2025 • 10 Pediatric Vaccines Market Size and Forecast(Value),2010 - 2025 • Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market • A Comprehensive List of Key Market Players Along with the Analysis of their Current Product Portfolios and Latest Recent Development and Trends The following key questions have been addressed in the report: • What is the size of the United States pediatric vaccines market during 2010 -2025? • How will each segment of the United States pediatric vaccines market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2025? • Which major pediatric vaccines provides highest market share? • How much number of children being vaccinated during 2010-2025? • How are the overall market and segments types growing? • What are the major market drivers and inhibitors in the United States pediatric vaccines market? • Who are the key players in the United States pediatric vaccines market and what are their contributions?


Global Non-Invasive Prenatal Testing Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025

March 2020

Global Non-Invasive Prenatal Testing(NIPT) market is anticipated to grow over US$ 2.5 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 - 2025. The market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non-invasive techniques over invasive methods. “Global Non-Invasive Prenatal Testing Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025” presents an in-depth assessment of the Global Non-Invasive Prenatal Testing (NIPT) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for Global Non-Invasive Prenatal Testing (NIPT). The research includes historic data from 2014 to 2017 and forecasts until 2025. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of NIPT tests and Countries-based market. The report also includes assessment of comparative test analysis by companies. Additionally, the report includes insights into the Global perspectives on clinical adoption of NIPT. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Non-Invasive Prenatal Testing (NIPT) market. The report concludes with the profiles of major players in the Global Non-Invasive Prenatal Testing (NIPT) market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolios and latest development and trends of the Non-Invasive Prenatal Testing (NIPT) market. Key Findings: • United States is anticipated to be the most attractive market in the Global Non-Invasive Prenatal Testing(NIPT) market • China NIPT test market is set to cross USD 400 Million by 2025 • Panorama test accounted for the highest share in Global Non-Invasive Prenatal Testing(NIPT) market • Verifi test has the second highest revenue share in the Global Non-Invasive Prenatal Testing(NIPT) market • Rising focus on Reimbursement for NIPT test will revolutionize the market • Two–Child policy is likely to boost China NIPT market The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are: Illumina, Natera, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche), BGI Diagnosis Co. Ltd, Berry Genomics, Quest Diagnostics, LifeCodexx AG, Premaitha Health, NIPD Genetics Major and Promising Non-Invasive Prenatal Testing (NIPT) Covered Under This Report are: Panorama, MaterniT21 PLUS, Harmony, Verifi, NIFTY, IONA, PrenaTest, Bambni, Veracity and Other Tests Major Countries Analyzed Under This Report are: United States, China, Japan, India, Brazil, Australia, New Zealand, United Kingdom, Germany, Italy, Spain, France, Switzerland, Sweden, Belgium, Russia, Turkey, Netherland, Poland, Armenia, Moldova, Denmark and Rest of the Countries. The Latest Industry Data Included in this Report: • Global Non–Invasive Prenatal Testing Market Volume & Future Trends (2014 – 2025) • Global Non–Invasive Prenatal Testing Market Revenue & Future Trends (2014 – 2025) • Global Non–Invasive Prenatal Testing Market Share and Y–o–Y Growth (%) • Market Share Analysis, by Test, 2014 - 2025 (%) • Market Share Analysis, by Major Countries, 2014 – 2025 (%) • Global Non–Invasive Prenatal Testing Market, By Test (Volume and Value),2011 – 2025 • Global Non–Invasive Prenatal Testing Market, By Geography (Volume and Value),2014 – 2025 • Non–Invasive Prenatal Testing(NIPT) Comparative Analysis – By Test • Major Deals in Global Non–Invasive Prenatal Testing Market • Global Perspectives on Clinical Adoption of NIPT • Global Non–Invasive Prenatal Testing Market Drivers and Inhibitors • Key Companies Analysis


Europe Non–Invasive Prenatal Testing Market Research Report 2018

March 2020

Europe Non–Invasive Prenatal Testing market is set to touch US$ 500 Million by 2025. The market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non–invasive techniques over invasive methods. “Europe Non–Invasive Prenatal Testing Market Research Report 2018” presents an in–depth assessment of the Europe non–invasive prenatal testing market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the market situation and future outlook. The research includes historic data from 2014 to 2017 and forecasts until 2025. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of country–based market. The report also includes assessment of comparative test analysis by companies. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Europe non–invasive prenatal testing market. The superior geographic segments are identified in the report which studies NIPT test consumed and market revenue of the 15 countries. The countries included in this report are United Kingdom, Germany, Italy, Spain, France, Switzerland, Sweden, Belgium, Russia, Turkey, Netherland, Poland, Armenia, Moldova, Denmark from 2014 to 2017 and forecasts to 2025. The report concludes with the profiles of major players in the Europe non–invasive prenatal testing market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolios and latest development and trends of the non–invasive prenatal testing market. The major European companies dominating this market for its products, services and continuous product developments are: Ariosa Diagnostics (Roche), LifeCodexx AG, Premaitha Health PLC and NIPD Genetics Major and Promising NIPT Test Available in the European Region are: • Panorama • MaterniT21 PLUS • Harmony • Verifi • NIFTY • IONA • PrenaTest • Veracity Major European Countries Analyzed Under This Report are: • United Kingdom • Germany • Italy • Spain • France • Switzerland • Sweden • Belgium • Russia • Turkey • Netherland • Poland • Armenia • Moldova • Denmark Major European NIPT Test Companies Analysis • Ariosa Diagnostics (Roche) • LifeCodexx AG • Premaitha Health PLC • NIPD Genetics Key questions answered in this research report: • At what pace is the NIPT test market growing in Europe? What will be growth trend in future? • What are the key drivers and inhibitors in the current market? What will be the impact of drivers and inhibitors in the future? • What is the country revenue and forecast breakdowns? Which is the major country revenue pockets for growth in the NIPT test market? • What are the various NIPT test available in the European region and how they are poised to grow? • How is the market predicted to develop in the future? • Who are the market players?


United States Influenza Vaccines Market Report, Analysis and Forecast to 2025

March 2020

United States Influenza Vaccines market is set to touch US$ 3.5 Billion threshold by 2025. “United States Influenza Vaccines Market Report, Analysis and Forecast to 2025” presents an in-depth assessment of the United States influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for United States influenza vaccines market. The report includes historic data from 2013 to 2017 and forecasts until 2025. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the united states influenza vaccines market. The report also explores detailed analysis of number of children and adults vaccinated with influenza vaccines in United States from 2013 to 2017 and forecasts to 2025. The report also details the latest information about the influenza vaccines production, supply, and allocation by major companies in United States. A comprehensive analysis has been done on pricing, distribution & demand and effectiveness of influenza vaccines in United States. It also provides a deep and thorough evaluation of distribution channel & technique of influenza vaccination. It covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States influenza vaccines market. The report concludes with the profiles of major players in the United States influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and recent development of influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi TanabePharma and Biondvax Pharmaceuticals Ltd, are making novel technology-based influenza vaccines which is likely to affect the market share during the forecast period. The major companies dominating this market for its products, services and continuous product developments are: Seqirus, Sanofi Pasteur, GlaxoSmithKline (GSK) and AstraZeneca The Latest Industry Data Included in this Report: • United States Influenza Vaccines Market Size & Analysis (2013 - 2025) • United States Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025) • United States Number of Children Vaccinated with Influenza Vaccines (2013 - 2025) • United States Number of Adults Vaccinated with Influenza Vaccines (2013 - 2025) • United States Influenza Vaccines Pricing Trends & Analysis • United States Influenza Vaccines Production, Supply, and Allocation (By Companies) • United States Influenza Vaccines Distribution & Demand (2010 - 2018) • Effectiveness of Influenza Vaccines in United States (2004 – 2018) • Rapid Diagnostic Testing for the Management of Influenza • Distribution Channel & Technique of Influenza Vaccination in United States • United States Influenza Vaccines Reimbursement Policies & Regulatory System • Major Deals in United States Influenza Vaccines Market • Promising Influenza Vaccines in Clinical Development • Influenza Vaccines Clinical Trial Insights by Phase, Company & Country • Market Definition for the Specified Topic Along with Identification of Key Driver and Inhibitors for the Market • A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis and Recent Development Key questions answered in this research report: • At what pace is the influenza vaccines market growing in United States? What will be growth trend in future? • How much number of persons being vaccinated with influenza vaccines during 2013 - 2025? • What are the key drivers and inhibitors in the current market? What will be the impact of drivers and inhibitors in the future? • What are the various influenza vaccines available in the United States? • How is the market predicted to develop in the future? • Who are the key players in this market space?


United States Vaccines Market 2015 - 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts

March 2020

United States vaccines market is set to surpass US$ 21 Billion threshold by 2025. “United States Vaccines Market 2015 - 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the United States vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for United States vaccines market. The report includes historic data from 2015 to 2017 and forecasts until 2025. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the United States vaccines market. The report also explores detailed analysis of top 21 vaccines market assessment in United States from 2015 to 2017 and forecasts to 2025. The report also details the latest information about the vaccines pricing trends and regulatory landscape in United States. Additionally, the report includes assessment of promising vaccines in the clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States vaccines market. The report concludes with the profiles of major players in the United States vaccines market. The key market players are evaluated on various parameters such as business overview, promising vaccines in the clinical development and recent development. The major companies dominating this market for its products, services and continuous product developments are: Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline(GSK) Top 21 Vaccines Covered Under This Report Are: Prevnar/Prevnar 13 Gardasil/Gardasil 9 Fluzone Varivax Menactra Proquad Pneumovax FluLaval/Fluarix Havrix/Twinrix/Engerix-B MMR II Adacel Boostrix Bexsero Menveo Trumenba Shingrix Pentacel Recombivax HB Rotateq Rotarix Pediarix/Infanrix The Latest Industry Data Included in this Report: United States Vaccines Market Size & Analysis (2015 - 2025) United States Vaccines Market Share & Y-o-Y Growth (%), 2015 – 2025 United States Top 21 Vaccines Market Assessment & Opportunity (2015 – 2025) United States Vaccines Pricing Trends & Analysis United States Vaccines Regulatory System Major Deals in United States Vaccines Market Promising Vaccines in Clinical Development by Major Companies Key Market Drivers and Inhibitors of the United States Vaccines Market Major Companies Analysis The answers to the following key questions can be found in the report: What is the size of the United States vaccines market during 2015 -2025? What will be the revenue generated by each vaccine during the forecast period? Which major vaccine provides highest market share? How are the overall market and vaccine type growing? What are the key drivers and inhibitors in the current market? What will be the impact of drivers and inhibitors in the future? What are the various vaccines available in the United States? How is the market predicted to develop in the future? Who are the key players in this market space?


Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

March 2020

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for global blockbuster drugs market. The report includes historic data from 2015 to 2017 and forecasts until 2025. The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global blockbuster drugs market. The report explores detailed analysis of top 50 drugs market assessment globally from 2015 to 2017 and forecasts to 2025. The report also details the latest information about the global research & development spend by pharma & biotech companies Additionally, the report includes assessment of most valuable drugs research and development projects insights by phase and market value. Key trends in terms of collaboration, merger & acquisition, partnerships and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global blockbuster drugs market. The report concludes with the profiles of major players in the global blockbuster drugs market. The key market players are evaluated on various parameters such as business overview and recent development. The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are: AbbVie Celgene Gilead Science Merck Roche Bristol–Myers Squibb Pfizer Johnson & Johnson Amgen Biogen Bayer Regeneron Pharmaceuticals Novo Nordisk Allergan Alexion Pharmaceuticals GlaxoSmithKline Novartis Eli Lilly and Company Astrazeneca Incyte Corporation Boehringer Ingelheim Astellas Pharma Top 50 Blockbuster Drugs Covered Under This Report Are: 1) Humira 2) Imbruvica 3) Revlimid 4) Genvoya 5) Truvada 6) Harvoni 7) Epclusa 8) Keytruda 9) Januvia/Janumet 10) Herceptin 11) Avastin 12) MabThera/Rituxan 13) Perjeta 14) Opdivo 15) Eliquis 16) Orencia 17) Sprycel 18) Lyrica 19) Ibrance 20) Simponi 21) Stelara 22) Zytiga 23) Invega Sustenna 24) Xarelto 25) Enbrel 26) Tagrisso 27) Tecfidera 28) Eylea 29) Victoza 30) Botox 31) Soliris 32) Triumeq 33) Seretide/Advair 34) Gilenya 35) Cosentyx 36) Trulicity 37) Cialis 38) Humalog 39) Symbicort 40) Zepatier 41) Pomalyst/Imnovid 42) Darzalex 43) Prolia/Xgeva 44) Ocrevus 45) Xtandi 46) Tivicay 47) Jakafi/Jakavi 48) Jardiance 49) Trajenta / Jentadueto 50) Relvar/Breo Ellipta The Latest Industry Data Included in this Report: Global Top 50 Blockbuster Drugs Market Size & Analysis (2015 – 2025) Global Top 50 Blockbuster Drugs Market Share & Y–o–Y Growth (%), 2015 – 2025 Global Top 50 Blockbuster Drugs Market Assessment & Opportunity, (2015 – 2025) Most Valuable Drugs Research and Development (R&D) Projects Insights by Phase and Market Value Global Research & Development (R&D) Spend by Pharma & Biotech Companies (2015 – 2025) Major Deals (Mergers, Acquisitions, Key Agreements, Partnerships & Collaborations) Key Market Drivers and Inhibitors of the Global Blockbuster Drugs Market Major Companies Analysis The Answers to the Following Key Questions can be found in the Report: What is the size of the global top 50 blockbuster drugs market during 2015 -2025? What will be the revenue generated by each drug during the forecast period? Which major drugs provides highest market share? How are the overall market and major drugs growing? What are the key drivers and inhibitors in the current market? What will be the impact of drivers and inhibitors in the future? How is the market predicted to develop in the future? Who are the key players in this market space?


Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

March 2020

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscape, and discusses major trends. The report offers the most up-to-date industry data on the actual market situation, and future outlook for global human immunodeficiency virus (HIV) drugs market. The report includes historical data from 2015 to 2018, and forecasts until 2025. The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global human immunodeficiency virus (HIV) drugs market. The report explores detailed analysis of top 22 HIV drugs market assessment globally from 2015 to 2018 and forecasts to 2025. The report also details the latest happenings about the global research & development of HIV drugs. Additionally, the report includes an assessment of clinical trials and promising human immunodeficiency virus (HIV) drugs in clinical development. Key trends in terms of collaboration, partnerships, and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global human immunodeficiency virus (HIV) drugs market. The report concludes with the profiles of major players in the global human immunodeficiency virus (HIV) drugs market. The key market players are evaluated on various parameters such as business overview and recent development. The Major Companies Dominating this Market for its Drugs, Services and Continuous Drugs Developments are: • AbbVie • Merck • Gilead Sciences • Bristol–Myers Squibb • Janssen (Johnson&Johnson) • GlaxoSmithKline (GSK) Top 22 Human Immunodeficiency Virus (HIV) Drugs Covered Under this Report are: • Tivicay • Triumeq • Juluca • Epzicom • Selzentry • Kaletra • Sustiva • Reyataz • Atripla • Truvada • Viread • Complera • Stribild • Genvoya • Biktarvy • Descovy • Odefsey • Prezista/Prezcobix • Edurant • Isentress • Pifeltro • Delstrigo The Latest Industry Data Included in this Report: • Global HIV Drugs Market Size & Analysis (2015 – 2025) • Global HIV Drugs Market Share & Y-o-Y Growth (%),2015 – 2025 • Global Top 22 HIV Drugs Market Assessment & Opportunity (2015 – 2025) • Promising HIV Drugs in Clinical Development • HIV Drugs Clinical Trial Insight by Phase, Institute & Country,2018 • Major Deals (Key Agreements, Partnerships & Collaborations) • Latest Happenings in Global HIV Drugs Market • Key Drivers & Inhibitors of the Global HIV Drugs Market • Major Companies Analysis The Answers to the Following Key Questions can be found in the Report: • What is the size of the global HIV drugs market during 2015 -2025? • What will be the revenue generated by each drug during the forecast period? • Which major drug provides the highest market share? • How are the overall market and major drugs growing? • What are the key drivers and inhibitors in the current market? • What will be the impact of drivers and inhibitors in the future? • How is the market predicted to develop in the future? • Who are the key players in this market space?


Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025

March 2020

The global influenza vaccines market size is expected to surpass USD 6 billion by 2025. “Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025” presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global influenza vaccines market. The report includes historical data from 2013 to 2018 and forecasts until 2025. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the global influenza vaccines market. The report also explores a detailed analysis of the number of persons being vaccinated with influenza vaccines globally from 2013 to 2018 and forecasts to 2025. Additionally, the report includes assessment of clinical trials, promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. It also provides a deep and thorough evaluation of the distribution channel and technique of the influenza vaccination. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global influenza vaccines market. Further, prudent analysis has been done on the competitor’s part, where four major players grab a major share of the global influenza vaccine market by net sales. Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus (CSL Limited) and AstraZeneca are the key influencers with their vaccines in the global influenza vaccines market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, Altimmune, FluGen, Moderna, Vaccitech, VaxInnate and BioDiem are making novel technology-based influenza vaccine which is likely to affect the market share during the forecast period. The report concludes with the profiles of major players in the global influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and recent development in the global influenza vaccines market. The major and emerging companies dominating this market for its vaccines, services and continuous product developments are: • Sanofi Pasteur • GlaxoSmithKline (GSK) • Seqirus (CSL Limited) • AstraZeneca • Mylan • Sinovac Biotech Ltd. • Gamma Vaccines Pty Ltd. • Hualan Biological Engineering Inc. • Shanghai Institute of Biological Products Co., Ltd. • Novavax • Daiichi–Sankyo • Mitsubishi Tanabe Pharma • BiondVax Pharmaceuticals Ltd • Altimmune • FluGen • Moderna • Vaccitech • VaxInnate • BioDiem Twenty-One Major Markets (21MM) covered in the report are as follows: • United States • Canada • Germany • France • Italy • Spain • United Kingdom • Netherlands • Sweden • Denmark • Poland • Norway • Finland • Ireland • Belgium • Australia • New Zealand • Japan • Brazil • China • India The Latest Industry Data Included in this Report: • Global Influenza Vaccines Market Size and Analysis (2013 – 2025) • Global Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025) • Global Influenza Vaccines Market Share Analysis and Forecast (2013 – 2025) • Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast (2013 – 2025) • Global Influenza Vaccines Market in Top 21 Countries and Forecast (2013 – 2025) • Rapid Diagnostic Testing for the Management of Influenza • Global Distribution Channel and Technique of Influenza Vaccination • Promising Influenza Vaccines in Clinical Development • Major Deals in the Global Influenza Vaccines Market • Influenza Vaccines Clinical Trial Insights by Phase, Company & Country • Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market • A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis, and Recent Development The Report Answers the Following Questions about the Global Influenza Vaccines Market: • How has the global influenza vaccines market performed so far and how will it perform in the coming years? • What are the key markets in the global influenza vaccines industry? • How many numbers of persons being vaccinated with influenza vaccines globally during 2013 – 2025? • What are the key drivers and inhibitors in the current market? • What are the various influenza vaccines available globally? • How is the market predicted to develop in the future? • Who are the key players in this market space?


Page : 386



Contact Us

Address

Pride Icon, Office No - 709,Thite Nagar, Kharadi,Pune, Maharashtra, India 411014

Phone Number

+(210) 775-2636